<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03701867</url>
  </required_header>
  <id_info>
    <org_study_id>BL39</org_study_id>
    <nct_id>NCT03701867</nct_id>
  </id_info>
  <brief_title>Muscle Energy Metabolism and Metabolic Flexibility in Older Men and Women</brief_title>
  <official_title>A Pilot Study to Explore Muscle Energy Metabolism and Metabolic Flexibility in Older Men and Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Nutrition</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Nutrition</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will explore differences in energy metabolism and metabolic flexibility under&#xD;
      various conditions in older men and women.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 14, 2018</start_date>
  <completion_date type="Actual">July 22, 2019</completion_date>
  <primary_completion_date type="Actual">July 22, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Respiratory Quotient</measure>
    <time_frame>Baseline to 270 minutes</time_frame>
    <description>Ratio of macronutrient oxidation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood Biochemistries - Glucose</measure>
    <time_frame>Baseline to 270 minutes</time_frame>
    <description>Venous blood sample</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Biochemistries - Insulin</measure>
    <time_frame>Baseline to 270 minutes</time_frame>
    <description>Venous blood sample</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Biochemistries - Amino Acids</measure>
    <time_frame>Baseline to 270 minutes</time_frame>
    <description>Venous blood sample</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Biochemistries - Fatty Acids</measure>
    <time_frame>Baseline to 270 minutes</time_frame>
    <description>Venous blood sample</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle Oxygenation</measure>
    <time_frame>Baseline to 270 minutes</time_frame>
    <description>Near Infrared Spectroscopy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle Fatigue</measure>
    <time_frame>Baseline to 270 minutes</time_frame>
    <description>Electromyography</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">22</enrollment>
  <condition>Energy Metabolism</condition>
  <arm_group>
    <arm_group_label>Metabolic Flexibility Tests Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Metabolic Flexibility Tests</intervention_name>
    <description>Energy Metabolism, Oxygenation, Body Composition, Blood Samples</description>
    <arm_group_label>Metabolic Flexibility Tests Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Body mass index (BMI) &gt;20.0 and &lt;39.0 kg/m2&#xD;
&#xD;
          -  Ambulatory (may use assistance device e.g., cane, walker)&#xD;
&#xD;
          -  Not a current smoker (within past 10 years)&#xD;
&#xD;
          -  Low or moderate risk based on the responses from the AHA/ACSM Health/Fitness Facility&#xD;
             Preparticipation Screening Questionnaire&#xD;
&#xD;
          -  Normal muscle mass and strength/performance or sarcopenia included in low muscle mass&#xD;
             and low grip strength&#xD;
&#xD;
          -  If on thyroid medication or hormone replacement therapy, has been on a constant dosage&#xD;
             for at least 2 months prior to Screening Visit&#xD;
&#xD;
          -  Willingness to follow protocol as described&#xD;
&#xD;
          -  Voluntarily signed and dated an informed consent form (ICF), approved by an&#xD;
             Independent Ethics Committee (IEC)/Institutional Review Board (IRB) prior to any&#xD;
             participation in the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Active/treated disease, under the care of a physician, for the following:&#xD;
             metabolic/endocrine (diabetes), hepatic, or renal disease, myocardial infarction,&#xD;
             peripheral vascular disease, respiratory or neuromuscular disease&#xD;
&#xD;
          -  Participates in a resistance exercise program&#xD;
&#xD;
          -  Poor appetite with recent unexplained weight loss over the past 6 months&#xD;
&#xD;
          -  Current infection (requiring medication or which might be expected to require&#xD;
             hospitalization); has had inpatient surgery, or corticosteroid treatment (excluding&#xD;
             topical creams) in the last 3 months or antibiotics in the last 3 weeks.&#xD;
&#xD;
          -  Active malignancy, excluding carcinoma in-situ of the cervix, cutaneous malignancies&#xD;
             (basal cell carcinoma, squamous cell carcinoma, except melanoma)&#xD;
&#xD;
          -  Chronic, contagious, infectious disease, such as active tuberculosis, Hepatitis A, B&#xD;
             or C, or HIV&#xD;
&#xD;
          -  Taking medications/dietary supplements or substances that could profoundly modulate&#xD;
             metabolism in the opinion of the principal investigator or study physician, Exceptions&#xD;
             for multi-vitamin/mineral supplement, topical or optical steroids and short-term use&#xD;
             (less than two weeks) of dexamethasone&#xD;
&#xD;
          -  Allergy or intolerance to any foods&#xD;
&#xD;
          -  History of gastrointestinal disease, or surgeries, gastroparesis, or taking&#xD;
             medications that are known in the opinion of the PI or study physician to interfere&#xD;
             with consumption/digestion/absorption of nutrients&#xD;
&#xD;
          -  Eating disorder, severe dementia or delirium, history of significant neurological or&#xD;
             psychiatric disorder, alcoholism, substance abuse or other conditions that may&#xD;
             interfere with compliance with study protocol procedures in the opinion of the&#xD;
             principal investigator or study physician&#xD;
&#xD;
          -  Participant in a concomitant AN trial or trial of a non-registered drug (or is within&#xD;
             the 30 day follow-up period for such a trial) or that otherwise conflicts with this&#xD;
             study unless otherwise approved&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vikkie Mustad, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Abbott Nutrition</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Nebraska</name>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <zip>68508</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>September 21, 2018</study_first_submitted>
  <study_first_submitted_qc>October 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 10, 2018</study_first_posted>
  <last_update_submitted>August 26, 2019</last_update_submitted>
  <last_update_submitted_qc>August 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 28, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

